Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | CRL | TMO |
|---|
| Close | 273.41 | 648.43 |
| Market Cap | $13.1B | $240B |
| 1M | −4.62% | +10.75% |
| P/E (TTM) | — | 34.4 |
| Forward P/E | 24.2 | 21.8 |
| P/E 5-Yr Percentile | — | 65 |
| P/S | 3.3 | 5.2 |
| P/B | 4.6 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.0B | $12.0B |
| Revenue YoY | −2.7% | +10.5% |
| Gross Margin | — | — |
| Latest Quarter EPS | -0.03 | 4.68 |
| Avg Post-Earnings Move | ±1.8% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.48% | 2.36% |
| 90-Day Net Insider Buying | −$42.6M | −$38.9M |
CRL · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
